Article
Lack of functional erythropoietin receptors of cancer cell lines
7 Nov 2007
Abstract excerpt
Erythropoietin (Epo) therapy reduces red cell transfusion requirements and improves the quality of life of anemic cancer patients receiving chemotherapy. However, there is concern that Epo may promote tumor growth. We investigated by real-time RT-PCR, immunofluorescence microscopy, Western blotting and cell growth analysis whether human cancer cell lines (SH-SY5Y, MCF7, HepG2, U2-OS, HeLa, HEK293T, RCC4, HCT116,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
